iwCAR-T 2023

The 5th International Workshop on CAR-T

14–16 April 2023 | Scottsdale, AZ

Explore presentations by leading experts from iwCAR-T 2023 below.

Emerging CARs and future challenges Genitourinary cancers Lung cancer Logistics & manufacturing Gastrointestinal cancers Head/neck and CNS cancers Melanoma & sarcomas

Session 1: Emerging CARs and future challenges in solid tumors

Mathew Angelos

HER2-targeted CAR-macrophages for solid tumors

Mathew Angelos University of Pennsylvania

Sebastian Kobold

Migratory engineering of T cells for cancer therapy

Sebastian Kobold Ludwig Maximilian University of Munich

Session 2: Genitourinary cancers

Vivek Narayan

Next steps in safety and efficacy for CAR-T

Vivek Narayan University of Pennsylvania, Philadelphia, PA

Nicholas Zorko

NK cells for GU malignancies

Nicholas Zorko University of Minnesota

David Hong

Autologous T-cells engineered with TCRs

David Hong The University of Texas MD Anderson Cancer Center

Session 3: CAR-T clinical advances in lung cancer

Adam Schoenfeld

Updates on TIL therapy in lung cancer

Adam Schoenfeld Memorial Sloan Kettering Cancer Center

William Go

The challenges and the future of cell therapy

William Go A2 Biotherapeutics, Agoura Hills, CA

Session 4: Logistics & manufacturing

Julian Molina

CAR T-cell studies in solid tumors - logistic issues

Julian Molina Mayo Clinic, Rochester, MN

Sarah Nikiforow

Manufacturing/FACT and ASTCT 80/20

Sarah Nikiforow Dana-Farber Cancer Institute

Session 5: Gastrointestinal cancers

Joel Randolph Hecht

GI malignancies; I-O to cell therapy

Joel Randolph Hecht UCLA Health, Los Angeles

Diane Simeone

scSeq in pancreatic cancer

Diane Simeone NYU Langone Health, New York City, NY

Benjamin Schlechter

TAC01-HER2 cell therapy in HER2+ solid tumors

Benjamin Schlechter Dana-Farber Cancer Institute

Zhaohui Jin

2-specific chimeric antigen receptor T-cell therapy

Zhaohui Jin Mayo Clinic

Session 6: Head/neck and CNS cancers

Jong Chul Park

Development of novel therapeutics for H&N cancer

Jong Chul Park Massachusetts General Hospital

Kedar Kirtane

Cellular immunotherapy in head and neck cancers

Kedar Kirtane H. Lee Moffitt Cancer Center & Research Institute

Rizwan Romee

Engineering NK cells for enhanced solid tumor targeting

Rizwan Romee Dana-Farber Cancer Institute

Session 7: Melanoma & sarcomas

Sebastian Klobuch

Tumor-infiltrating lymphocyte therapy

Sebastian Klobuch The Netherlands Cancer Institute

John Mullinax

Intraoperative principles related to TIL procurement

John Mullinax H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL

The continued success of the iwCAR-T meeting is in no small part due to the ongoing funding of supporters, allowing a unique opportunity for clinicians to be brought together to facilitate interactive and stimulating debates to help improve patient outcomes.
For more information about supporting future meetings and activities, please contact us here.

iwCAR-T 2023 was supported by: